deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT01573403

Efficacy and Safety of DLBS2411 in Healthy Volunteers

Effect of DLBS2411 on Gastric pH Regulation in Healthy Volunteers : Comparison With Placebo

Sponsor: Dexa Medica Group

Conditions Gastric pH Regulation in Healthy Volunteers
Interventions DLBS2411 Placebo DLBS2411
Updated 5 times since 2017 Last updated: Feb 12, 2013 Started: Apr 30, 2012 Primary completion: Dec 31, 2012 Completion: Jan 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01573403, this PHASE1/PHASE2 trial focuses on Gastric pH Regulation in Healthy Volunteers and remains completed. Sponsored by Dexa Medica Group, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dexa Medica Group
Data source: Dexa Medica Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations